Company intelligence / Profile preview

来益医药

杭州市(Hangzhou), 浙江省(Zhejiang Province), 中国(China)
Ownership
Private
Development stage
Other
01

Overview

来益医药 is a pharmaceutical distribution and retail company with a focus on the wholesale and retail of drugs, medical devices, health products, and food. It also has manufacturing capabilities through its related entity Zhejiang Laiyi Biotechnology for tablets and capsules. The main product lines include anti-tuberculosis drugs and anti-infective agents among others. No clinical trial data or innovative pipeline was found.

Therapeutic areas
Infectious DiseasesOther
Modalities
Small moleculeBiologic
Industry
Non-Academic Healthcare

Beyond the preview

Go deeper on 来益医药.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 来益医药.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call